Total Payments
$5,389
2024 Payments
$611.67
Companies
24
Transactions
373
Payment Breakdown by Category
Food & Beverage$5,337 (99.0%)
Education$51.44 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,337 | 371 | 99.0% |
| Education | $51.44 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,473 | 99 | $0 (2024) |
| ABBVIE INC. | $883.25 | 70 | $0 (2024) |
| Lundbeck LLC | $707.96 | 54 | $0 (2024) |
| Allergan, Inc. | $413.23 | 38 | $0 (2020) |
| ITI, Inc. | $310.60 | 13 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $244.48 | 15 | $0 (2024) |
| Shire North American Group Inc | $233.02 | 14 | $0 (2019) |
| Alkermes, Inc. | $200.62 | 7 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $176.56 | 10 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $166.37 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $611.67 | 38 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($176.56) |
| 2023 | $1,114 | 62 | AbbVie Inc. ($488.51) |
| 2022 | $485.77 | 32 | Alkermes, Inc. ($141.23) |
| 2021 | $397.20 | 33 | AbbVie Inc. ($128.95) |
| 2020 | $480.55 | 40 | Allergan, Inc. ($199.31) |
| 2019 | $688.89 | 48 | Otsuka America Pharmaceutical, Inc. ($328.55) |
| 2018 | $857.39 | 61 | Otsuka America Pharmaceutical, Inc. ($327.05) |
| 2017 | $753.09 | 59 | Otsuka America Pharmaceutical, Inc. ($300.07) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 2 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/03/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: ADHD | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: PSYCHIATRY | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: PSYCHIATRY | ||||||
| 03/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: PSYCHIATRY | ||||||
| 01/11/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: ADHD | ||||||
| 01/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: PSYCHIATRY | ||||||
| 01/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $36.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: PSYCHIATRY | ||||||
| 11/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: PSYCHIATRY | ||||||
| 10/26/2023 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: ADHD | ||||||
| 10/25/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Paul Whitelock, M.D
Dr. Paul Whitelock, M.D is a Psychiatry healthcare provider based in San Marcos, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497764385.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Whitelock, M.D has received a total of $5,389 in payments from pharmaceutical and medical device companies, with $611.67 received in 2024. These payments were reported across 373 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($5,337).
Ad
Practice Information
- Specialty Psychiatry
- Location San Marcos, TX
- Active Since 08/07/2006
- Last Updated 03/06/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1497764385
Products in Payments
- REXULTI (Drug) $2,014
- VRAYLAR (Drug) $1,296
- CAPLYTA (Drug) $487.16
- Fanapt (Drug) $222.85
- LATUDA (Drug) $166.37
- MYDAYIS (Drug) $153.38
- LYBALVI (Drug) $137.45
- TRINTELLIX (Drug) $136.90
- Dyanavel XR (Drug) $117.07
- Trintellix (Drug) $114.83
- VYVANSE (Drug) $92.40
- ARISTADA (Drug) $63.17
- BRINTELLIX (Drug) $57.61
- Auvelity (Drug) $47.03
- Xelstrym (Drug) $36.80
- ABILIFY MYCITE (Drug) $35.28
- BELSOMRA (Drug) $26.37
- FANAPT (Drug) $21.63
- ABILIFY MAINTENA (Drug) $20.03
- NUEDEXTA (Drug) $18.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Marcos
Dr. Alan Berkowitz, Md, MD
Psychiatry — Payments: $13,876
Psychiatry $13,876
Sheila Cai, Md, MD
Psychiatry — Payments: $6,705
Psychiatry $6,705
Dr. Josefa Licas, M.d, M.D
Psychiatry — Payments: $5,218
Psychiatry $5,218
Dr. Garrick Tong, M.d, M.D
Psychiatry — Payments: $2,948
Psychiatry $2,948
Mr. Arvin Mirow, Md, MD
Psychiatry — Payments: $2,734
Psychiatry $2,734
Mr. Dennis Ordas, Md, MD
Psychiatry — Payments: $2,205
Psychiatry $2,205